Last updated: February 19, 2025
Sponsor: Mihriban Culha
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
kaleidescope
Clinical Study ID
NCT06261112
B.30.2.ATA.01.11/285
Ages 6-12 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Being a child in the 6-12 age group,
The child's willingness to participate in the study,
The parent's volunteering to participate in the study,
Absence of intellectual disability of the child and parent,
The child and the parent speak Turkish and are open to communication.
Exclusion
Exclusion Criteria:
The child has a chronic disease that can cause pain,
The child has used analgesics within 24 hours before admission to the hospital,
The child has visual impairment.
Study Design
Total Participants: 70
Treatment Group(s): 1
Primary Treatment: kaleidescope
Phase:
Study Start date:
May 07, 2022
Estimated Completion Date:
September 01, 2024
Study Description
Connect with a study center
Ataturk University
Erzurum, 25240
TurkeySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.